Last Updated: 31/10/2025
Safety, tolerability and pilot efficacy of short course, high dose primaquine treatment for liver stages of Plasmodium vivax infection
Objectives
The primary objective of this project is to assess the safety and tolerability of short course, high dose primaquine treatment in children.
Secondary objectives:
- assess the pharmacokinetics of primaquine in children after high oral doses;
- determine the efficacy of short course high dose primaquine compared to the standard 14 day treatment.
* Clinical Trial title: Investigation of Short Course, High Dose Primaquine Treatment for Liver Stages of Plasmodium Vivax Infection
Principal Institution
Principal Investigators / Focal Persons
Partner Investigators
Study Design
ClinicalTrials.gov ID: NCT02364583
Study Type: Interventional
Study Phase: Phase 4
Study Design:
Allocation: Non-Randomized
Interventional Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
External reference
Date
Jun 2010 — Dec 2018
Funding Details
Country / Project Site(s)
Related Resources
